Author name: ipessentiacom

Spinal Muscular Atrophy (SMA) is a rare genetic disorder that causes progressive muscle weakness and wasting, impacting voluntary muscle movement. […]

Sanofi’s recent infringement lawsuits at the Unified Patent Court (UPC) mark a pivotal moment for pharmaceutical patent litigation. Background: Sanofi’s

Update: Teva Granted 30-Day Stay on Inhaler Patents’ Orange Book Delisting Last week, a federal judge in New Jersey granted

Sandostatin (Octreotide) LAR is used for treating acromegaly, carcinoid tumors, and neuroendocrine tumors, among other conditions. Novartis owned EP 2377519,

In a recent decision, the Swedish Patent and Market Court provided critical insights into the interpretation of Article 3(b) and

In the United Kingdom, multiple generic competitors initiated invalidity lawsuits seeking revocation of Bayer’s key dosing patent protecting Xarelto 10,

https://womenentrepreneurindia.com/digital-magazine/women-in-pharma-and-lifesciences-may-2022/#page=32     #womeninpharma #ipservices #patentservices

#honor #recognition #gratitude #ipessentia

Thanks, Garima & Sneha for discussing TICAGRELOR, DAPAGLIFLOZIN, CHLORANTRANILIPROLE and SAROGLITAZAR cases at length & sharing the shifting trend.  

Thanks, Bird & Bird, Life Sciences team…….. Mark Hilton & Jane Owen, for sharing the recent shift in Interim injunctions